Introduction to antimicrobial agents

Similar documents
Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Mechanism of antibiotic resistance

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Antimicrobials & Resistance

Other Beta - lactam Antibiotics

Antimicrobials. Antimicrobials

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Antimicrobial agents. are chemicals active against microorganisms

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Global Alliance for Infections in Surgery. Better understanding of the mechanisms of antibiotic resistance

Microbiology ( Bacteriology) sheet # 7

Antimicrobial Resistance

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Penicillins, cephalosporins, carbapenems monobactams

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Antibiotics & Resistance

Antibiotic Resistance in Bacteria

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

D4/D5 The Miracle Drug

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Antimicrobial chemotherapy - history - principles and practice - mode of action, resistance. Dr. Berek Zsuzsa. 01 October 2013

chapter 15 microbial mechanisms of pathogenicity

WHY IS THIS IMPORTANT?

Multi-drug resistant microorganisms

An#bio#cs and challenges in the wake of superbugs

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Antimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Antimicrobial Resistance and Prescribing

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Antibiotics (2): - Before you start: this lecture has a lot of names and things get entangled together, but I

Antimicrobial Therapy

Antimicrobial agents

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Pharmacology Week 6 ANTIMICROBIAL AGENTS

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Antimicrobial Therapy

Beta-lactams 1 รศ. พญ. มาล ยา มโนรถ ภาคว ชาเภส ชว ทยา. Beta-Lactam Antibiotics. 1. Penicillins 2. Cephalosporins 3. Monobactams 4.

Infectious Disease: Drug Resistance Pattern in New Mexico

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems

Protein Synthesis Inhibitors

Antibiotic resistance a mechanistic overview Neil Woodford

What s next in the antibiotic pipeline?

Antimicrobial drugs Antimicrobial drugs

January 2014 Vol. 34 No. 1

Antibiotics 101 for Laboratory Professionals: Part Two

دکتر فرينبز راشذ مرنذی متخصص آسيب شنبسی تشريحی و ببلينی عضو هيئت علمی آزمبيشگبه مرجع سالمت

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

2015 Antibiotic Susceptibility Report

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

2016 Antibiotic Susceptibility Report

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Chapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L.

Antibiotics 1. Lecture 8

control microbial growth in vivo

Controlling Microbial Growth in the Body: Antimicrobial Drugs

num Doctor Done by Corrected by Maha AbuAjamieh Lara Abdallat Dr. Malik

CONTAGIOUS COMMENTS Department of Epidemiology

Beta-lactam antibiotics - Cephalosporins

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

bacteria fungi HOW? WHAT? protozoa virus Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

European Committee on Antimicrobial Susceptibility Testing

56 Clinical and Laboratory Standards Institute. All rights reserved.

Management of Antibiotic Resistant Pathogens

Approach to pediatric Antibiotics

European Committee on Antimicrobial Susceptibility Testing

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

Addressing the evolving challenge of β-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broadspectrum

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Mechanisms of Antimicrobial Action and Resistance. Alan L. Goldin, M.D./Ph.D.

Evolution of antibiotic resistance. October 10, 2005

Transcription:

Introduction to antimicrobial agents Kwan Soo Ko

Action mechanisms of antimicrobials Bacteriostatic agents, such as tetracycline - Inhibit the growth and multiplication of bacteria - Upon exposure to a bacteriostatic agent, cell in a susceptible population stop dividing - If the agent removed, the cells once again multiply Bactericidal agents, such as fluoroquinolones - Not only inhibit the growth, but also trigger pathways within the cell that lead to cell death - The actions of bactericidal agents are irreversible so once susceptible cells exposed to a bactericidal agent, they die

Action mechanisms of antimicrobials Inhibition of cell wall synthesis Inhibition of protein synthesis Inhibition of nucleic acid synthesis (DNA or RNA) Antimetabolites

Inhibition of Cell Wall Synthesis The most common mechanism β-lactam antibiotics - penicillins, cephalosporins, cephamycins, carbapenems, monobactams, β-lactamase inhibitors Vancomycin, daptomycin, bacitracin, and antimycobacterial agents

Inhibition of Protein Synthesis The second largest class of antibiotics Aminoglycosides Tetracyclines Glycylcyclines Oxazolidinones Chlroamphenicol Macrolides Ketolides Clindamycin Streptogramins

Inhibition of Nucleic Acid Synthesis Inhibition of DNA synthesis - (Fluoro)quinolones Inhibition of RNA synthesis - Rifampin

Antimetabolites Sulfoamides & Trimethoprim - For many organisms, para-aminobenzoid acid (PABA) is an essential metabolite in the synthesis of folic acid, an important precursor to the synthesis of nucleic acids - Sulfonamides - Trimethoprim (TMP)

Penicillins & β-lactam Inhibitors Kwan Soo Ko

Penicillins By Alexander Fleming in 1928 - The Nobel Prize in Physiology or Medicine 1945 - "for the discovery of penicillin and its curative effect in various infectious diseases" Sir Alexander Fleming Ernst Boris Chain Sir Howard Walter Florey

Chemistry of penicillins β-lactam ring, essential for antibacterial activity Side chain for antibacterial spectrum and pharmacologic properties of a particular penicillin

Chemistry of penicillins Emergence of β-lactamase-producing organisms prompts development of compounds resistant to hydrolysis by β-lactamases Isolation of penicillin nucleus, 6-amino-penicillanic acid, from Penicillium chrysogenum production and testing of numerous semisynthetic penicillins methicillin against β-lactamase-producing S. aureus ampicillin against selected gram-negative bacilli carbenicillin against P. aeruginosa

S. aureus P. aeruginosa

Action mechanism of penicillins Inhibition of cell wall synthesis - Simply by blocking cell wall synthesis? overly simplistic! Synthesis of cell wall in bacteria - in a series of enzymatic steps involving at least 30 enzymes

Disaccharide monomer of N-acetylglucosamine (NAG) and N-acetylmuramic (NAM) pentapeptide Cytoplasmic reactions generating cell wall precursors & Transglycoslase reaction linking the subunit to peptidoglycan polymer not sensitive to penicillin

Action mechanism of penicillins Penicillin inhibits enzymes that catalyze the final step in bacterial cell wall assembly (formation of cross-links bridging peptidoglycan, giving structural integrity) Pentapeptide with amino acid residues alternating between L- and D-stereoisomers, terminating in D- alanyl-d-alanine

Action mechanism of penicillins Transpeptidation - formation of a amide bond between the terminal-free amine group of a stem peptide - penultimation of D-alanine of a pentapeptide, displacing the terminal D-alanine in the process - sensitive to inhibition by penicillin

Penicillin-binding proteins (PBPs) - Catalyze penicillin-sensitive reactions - Bifunctional enzymes (transpeptidase & transglycosylase) - Be inhibited by β-lactams through covalent binding of the active site serine residue - Binding to and inhibition of PBPs mediate the antibacterial activity of β-lactam antibiotics

Action mechanism of penicillins - β-lactams produce lethal effect on bacteria by inactivation of multiple PBPs, but inhibition of cell wall synthesis by itself is not necessarily lethal (nongrowing cells & osmotically protected cells) - Lethal effect in both gram-positive and gram-negative bacteria is probably cell-dependent - Inhibition of PBPs leads to disruption of a crucial event probably at the time of cell division - Disturbed morphogenesis is hypothesized to initiate cell death

Classification Conveniently, 5 classes on the basis of antibacterial activity (1)Natural penicillins, penicillin G & penicillin (2)Penicillinase-resistant penicillins, methicillin, nafcillin & isoxazolyl penicillins (3)Aminopenicillins, ampicillin & amoxicillin (4)Carboxypenicillins, carbenicillin & ticarcillin (5)Acyl ureidopenicillins, azlocillin, mezlocillin & piperacillin Carboxypenicillins & acyl ureidopenicillin - referred as antipeudomonal penicillins

Susceptibilities of penicillins Natural penicillins - most active against non-β-lactamase-producing grampositive bacteria, anaerobes, and selected gram-negative cocci (such as Neisseria) Semisynthetic penicillinase-resistant penicillins - only for penicillin-resistant S. aureus & S. epidermidis Aminopenicillins - same spectrum as penicillin G - active against non-β-lactamase-producing gram-negative cocci & Enterobacteriaceae

Susceptibilities of penicillins Carboxypenicillins & ureidopenicillins - active against ampicillin-resistant gram-negative aerobic rods, such as P. aeruginosa - Carboxypenicillins are less active against streptococci and Haemophilus spp. - Ureidopenicillins are more active against gram-negative bacteria other than Pseudomonas

β-lactamse inhibitors Clavulanic acid and penicillanic acid sulfone derivaties (themselves β-lactam compounds) Weak antibacterial activity - hydrolysis of β-lactam-carbonyl bond of β-lactams When combined with a β-lactam (substrate for class A β- lactamases), inhibitor prevent hydrolysis of antibiotic and thereby restoring its activity Three β-lactamase inhibitors in clinical use - Clavulanic acid, sulbactam & tazobactam - Each inhibitor is available only as a fixed-combination preparation - Effective only against Ambler class A β-lactamases

Clavulanic acid - Naturally occurring, weak antimicrobial agent (Streptomyces clavuligerus) -Inhibits β-lactamases from staphylococci and many gram-negative bacteria - Suicide inhibitor by forming an irreversible acyl enzyme complex with β-lactamase - Synergistic with various penicillins and cephalosporins

Sulbactam - Semisynthetic 6-desaminopenicillin sulfone with weak antibacterial activity - Effective inhibitor of certam plasmid-mediated and chromosomally mediated β-lactamases - Alone active against Neisseria gonorrhoeae, N. meningitis, and some Acinetobacter spp. - Synergically active with penicillins and cephalosporins

Tazobactam - Penicillanic acid sulfone derivative structurally related to sulbactam -Suicidal β-lactamase inhibitor - Binds to bacterial PBP1 or PBP2 - Available as a 1:8 ratio dosage combination with piperacillin

Resistance to penicillins Four mechanisms - Destruction of antibiotic by β-lactamase - Failure of antibiotic to penetrate the outer membrane of gram-negative bacteria to reach PBP targets - Efflux of drug across the outer membrane of gram-negative bacteria - Low-affinity binding of antibiotic to target PBPs

β-lactamase The most common in gram-negative bacteria - Covalently react with the β-lactam ring, rapidly hydrolyze, and destroy activity of the drug - Be categorized into four classes Ambler class A through D based on amino acid sequence similarity and molecular structure

β-lactamase Molecular Class Major Subtypes Preferred Substrates Inhibitor Gram-positive β-lactamase 2a Penicillins Clavulanate Gram-negative β-lactamase (e.g., TEM-1 and SHV-1) 2b Penicillins, some cephalosporins Clavulanate Main Genetic Localization Chromosomal or plasmid, inducible Plasmid or chromosomal A ESBL2be Inhibitor-resistant TEM β-lactamase 2br Carbenicillin-hydrolyzing β-lactamase 2c Cephalosporin hydrolyzing β-lactamase 2e Carbapenem hydrolyzing β-lactamase 2f Penicillins, narrow-spectrum and third-generation cephalosporins, monobactams Clavulanate Plasmid Penicillins Clavulanate? Plasmid Penicillins, carbenicillin Clavulanate? Plasmid Cephalosporins Clavulanate Chromosome, inducible Penicillins, cephalosporins, carbapenems B Metallo-β-lactamase 3 All β-lactams except monobactam C AmpC-type cephalosporinase 1 Cephalosporins, penicillins D Cloxacillin-hydrolyzing β-lactamase 2d Clavulanate EDTA, divalent cation chelators Cloxacillin, monobactams Chromosomal Chromosomal Penicillins, cloxacillin Clavulanate? Plasmid Chromosomal (inducible); constitutive, plasmidencoded enzymes increasingly reported

β-lactamase Class A, C & D - contain penicillin-binding motifs: PBPs - differ from other PBPs in that they typically are smaller in size and they are not cell wall synthetic enzymes - acylation of the active site serine and hydrolysis of the acyl intermediate in a deacylation reaction regenerating the active enzyme - deacylation rate of β-lactamase usually is greatly faster, rapidly hydrolyzing and turning over β-lactam molecules Class B - structuraly unrelated to PBPs -Zn 2+ -dependent enzymes: use different series of reactions to open the β-lactam ring

Class A β-lactamase Penicillinase (some, cephalosporinase or carbapenemase) Be inhibited by β-lactamase inhibitors such as clavulanic acid Point mutations resistance or extension of spectrum of activity including 3rd-generation cephalosporins and monobactams (extended-spectrum β-lactamases, ESBLs)

Other β-lactamase Class C β-lactamase - Cephalosporinases not inhibited by clavulanic acid - usually be encoded on the chromosome and inducible Class B β-lactamase - broad-spectrum enzymes - be inhibited by chelating agents - can hydrolyze all β-lactams except monobactams

Loss of porin in outer membrane Outer membrane of gram-negative bacteria - important barrier to drug penetration and important component of resistance β-lactamases of gram-negative bacteria - located in periplasmic space between inner cytoplasmic membrane and outer lipopolysaccharide membrane β-lactams can transverse porin channels to the periplasmic space and bind to target PBPs - Absence or deletion of a critical porin can result in resistance

Efflux Drug that enters the periplasmic space is pumped back across the outer membrane Independent to other mechanisms - but co-operation with exclusion of antibiotic by porins and destruction of antibiotic by β-lactamases Species difference in porins, pumps, β-lactamases, and target PBPs determined whether the organism is susceptible or resistant to a particular antibiotic

Production of PBP with low affinity Result of mutations in PBP genes - as in penicillin-resistant S. pneumoniae or Neisseria spp. Due to the presence of extra, low-affinity PBP - PBP5 by E. faecium or PBP2a by MRSA PBP2a - structural changes result in energetically unfavorable interactions between antibiotic and protein active site is inactivated not at all or too slowly to effectively block cell wall synthesis and bacterial growth